N. Kolla

发表

An efficient synthesis of dexlansoprazole employing asymmetric oxidation strategy

R. Bandichhor, N. Anitha, B. S. Reddy, 2011 .

(R)-(+)-2-{[(3-Methyl-4-nitropyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole1

R. Bandichhor, Peddy Vishweshwar, N. Kolla, 2011, Acta crystallographica. Section E, Structure reports online.

An Efficient and Impurity-Free Process for Telmisartan: An Antihypertensive Drug§

V. T. Mathad, Y. Anjaneyulu, N. Kolla, 2007 .

Boric Acid Catalyzed Amidation in the Synthesis of Active Pharmaceutical Ingredients

R. Bandichhor, A. Bhattacharya, N. Kolla, 2007 .

New Synthesis of Donepezil Through Palladium‐Catalyzed Hydrogenation Approach

N. Kolla, Himabindu Vurimidi, V. Sundaram, 2006 .

Efficient Synthesis of (1R)‐[3,5‐Bis(trifluoromethyl)phenyl] Ethanol, a Key Intermediate for Aprepitant, an NK‐1 Receptor Antagonist

Y. Anjaneyulu, M. Sreenivasulu, V. T. Mathad, 2007 .

An Alternative Approach to Achieve Enantiopure (3S)-4-Benzyl-3- (4-fluorophenyl)morpholin-2-one: A Key Intermediate of Aprepitant, an NK1 Receptor Antagonist†

V. T. Mathad, Y. Anjaneyulu, A. Bhattacharya, 2007 .

Substrate Modification Approach to Achieve Efficient Resolution: Didesmethylcitalopram: A Key Intermediate for Escitalopram#

V. T. Mathad, A. Bhattacharya, N. Kolla, 2007 .

A convergent approach to the synthesis of aprepitant: a potent human NK-1 receptor antagonist ☆

R. Bandichhor, V. T. Mathad, A. Bhattacharya, 2007 .

Effect of Solvent on Stereoselectivity in Pd/C (Type 39K)-Catalyzed Hydrogenation of Methyl 3-Oxo-4-aza-5-androstene-17-carboxylate, A Key Intermediate for Finasteride and Dutasteride #

R. Bandichhor, A. Bhattacharya, N. Kolla, 2007 .

Improved Process for Paroxetine Hydrochloride Substantially Free from Potential Impurities

R. Bandichhor, N. Kolla, A. Dongamanti, 2012 .